• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    HEALTHCARE (NY: XLV )

    149.11 +1.07 (+0.72%)
    Official Closing Price Updated: 8:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about HEALTHCARE

    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 13
    ...
    22 23 Next >
    Jefferies Financial, Apollo Global Management And A Major Sector ETF: CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Shannon Saccocia of NB Private Wealth said to watch for the health-care sector, naming Health Care Select Sector SPDR Fund (NYSE: XLV) 
    Via Benzinga
    Correction Bottom Searching
    Big picture, that‘s what we can expect in stocks over the coming weeks, making for a traders‘ market as select sectors are more richly valued than others. 
    Via Talk Markets
    Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
    Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
    Via Talk Markets
    Developing Your Uniqueness As A Trader
    Via Talk Markets
    2023 Midyear Review Of Index ETFs And Smart Beta Strategies & A Tribute To Harry Markowitz
    A review and analysis of the first 6 months of 2023 using benchmark ETFs, Sector ETFs, and Smart Beta ETFs and what is likely to follow next. 
    Via Talk Markets
    Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi
    Biogen's shares decline after approval of Alzheimer's treatment Leqembi, which modestly slows cognitive decline. Analysts see hurdles to the rollout. 
    Via MarketBeat
    Exposures Product Safety
    Thoughts For Thursday: Back From The Holiday With Caution
    Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China. 
    Via Talk Markets
    $1 Billion Deal For Moderna To Expand Product Pipeline in China
    Moderna is looking to diversify its falling U.S. product line, a $1 billion investment in China may act as the catalyst pushing the company's valuation higher 
    Via MarketBeat
    Topics ETFs Economy
    Exposures COVID-19 Economy
    Bullish Action: Chipotle, Visa, Stryker Break Through Resistance
    Chipotle, Visa, and Stryker recently broke out of chart bases, and remain in buy range on strong fundamental growth, institutional buying and analyst upgrades. 
    Via MarketBeat
    Biotech Blues: Stay Balanced Through July Earnings Season
    Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts. 
    Via Talk Markets
    S&P 500 Rallies Back To Highs As Apple, Nvidia Lead, But Watch For This; Tesla Deliveries Due
    Many stocks flashed buy signals. But was the pullback over too quickly? 
    Via Investor's Business Daily
    Biotech And Healthcare Stocks Lagging
    Healthcare is a laggard with XLV down YTD but UNH is still a core position. 
    Via Talk Markets
    D.R. Horton, Shake Shack And A Home Construction Company Up 32% This Year: CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc. 
    Via Benzinga
    Medical Stocks Waters, Agilent, Illumina Show Growth Potential
    Medical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts. 
    Via MarketBeat
    Countdown To ES Downleg
    The current rally is built on the false notion that recession has been and would be avoided, that earnings would start to rise, and that incoming data aren‘t generally bad. 
    Via Talk Markets
    More Balanced June
    Heading into the month of June, stock market performance this year was a clear case of the haves and the have-nots. 
    Via Talk Markets
    Wary Of Bull Market Chorus
    We‘re still in the euphoric stage of the rally that has a bit further to run, in spite of the wide Nasdaq vs. long-dated Treasury yields disconnect. 
    Via Talk Markets
    S&P 500 Low Volatility Index May 2023 Rebalance
    Since the last rebalance for the S&P 500 Low Volatility Index on Feb. 17, 2023, the S&P 500 finished up 3.2% despite briefly dropping in mid-March. 
    Via Talk Markets
    Two Charts That Can Help You See What’s To Come For The Markets
    While a handful of large companies have driven the stock market gains, the vast majority of stocks are down. 
    Via Talk Markets
    Bearish Vision As Apple Tests All-Time High
    Apple's first new product category in 8 years is a mixed-reality headset for $3499. 
    Via Talk Markets
    Market Mixes It Up With A Broad Rally
    Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
    Via Talk Markets
    Corporate Bankruptcies At Levels Last Seen During The Pandemic
    Despite all of the mainstream talk about a strong, resilient economy, corporate bankruptcies through the first four months of 2023 came in at the highest level since 2010. 
    Via Talk Markets
    Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?
    A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers. 
    Via Talk Markets
    Tech In Orbit
    Tech has led the way higher with a sharp move this week. The sector is now extremely overbought, trading 3.23 standard deviations above its 50-DMA; the fifth most overbought reading on record. 
    Via Talk Markets
    A Good Week For The Market But A Pause In The Biotech Rally
    Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness. 
    Via Talk Markets
    Your Mid-May Market Update: Sector Strength And Weakness So Far In 2023
    Today's session continued the ongoing theme of 
    Via Talk Markets
    Good Odds And Odd Goods
    Investing is all about making money. It is the realm where you go find out where the odds are good, even if the goods are odd. 
    Via Talk Markets
    5 Most-Loved ETFs Of Last Week
    Last week was marked by volatility. Overall, ETFs pulled in a modest $260 million in capital for the week, bringing total inflows of $111.7 billion year to date. 
    Via Talk Markets
    Something Happened In Biotech Last Week
    Biotech stocks were more constructive last week with some sharp moves up. 
    Via Talk Markets
    Seasonal Mid Point
    The next three months, which is the period straddling the back half of spring and the first half of summer, has been relatively strong in the last ten years. 
    Via Talk Markets
    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 13
    ...
    22 23 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.